Cannabis compound acts as an antibiotic

Public health agencies worldwide have identified antibiotic resistance of disease-causing bacteria as one of humanity’s most critical challenges. However, scientists haven’t discovered a new class of antibiotics in more than 30 years. Now, researchers reporting in

ACS Infectious Diseases

have uncovered the hidden antibiotic potential of a non-psychoactive cannabis compound called cannabigerol (CBG), which helped control methicillin-resistant

Staphylococcus aureus

(MRSA) infections in mice.

For centuries, cannabis plants have been used in folk medicine. Today, scientists are only beginning to investigate whether different cannabis compounds could be used to treat a variety of diseases. Early studies have shown that some cannabinoids can slow the growth of gram-positive bacteria, such as

S. aureus

, but not gram-negative bacteria, such as

E. coli

. Eric Brown and colleagues wanted to test the antibacterial properties of several cannabinoids against both MRSA and gram-negative bacteria.

The researchers tested the antibacterial activity of 18 cannabis-derived molecules, including cannabidiol (CBD), tetrahydrocannabinol (THC) and CBG, against MRSA. They also tested the ability of these substances to prevent the formation of biofilms on surfaces and to kill dormant “persistor” MRSA that are highly resistant to antibiotics. CBG performed the best in these tests, so the researchers chose to study it further. When they treated MRSA-infected mice with CBG, the compound worked as well as vancomycin, a powerful antibiotic. The researchers discovered that CBG targets the cell membrane of gram-positive bacteria, and by itself, it is not effective against gram-negative bacteria, which have an additional outer membrane. However, they found that if they gave CBG with another drug that pokes holes in this outer membrane, CBG could reach the inner membrane and kill gram-negative bacteria.

###

The authors acknowledge funding from the

Canada Research Chairs

program, the

Canadian Institutes of Health Research Foundation Grant Program

and the

Michael G. DeGroote Centre for Medicinal Cannabis Research

.

The abstract that accompanies this study is available

here

.

For more research news, journalists and public information officers are encouraged to apply for

complimentary press registration

for the ACS Spring 2020 National Meeting & Exposition in Philadelphia.

The American Chemical Society (ACS) is a nonprofit organization chartered by the U.S. Congress. ACS’ mission is to advance the broader chemistry enterprise and its practitioners for the benefit of Earth and its people. The Society is a global leader in providing access to chemistry-related information and research through its multiple research solutions, peer-reviewed journals, scientific conferences, eBooks and weekly news periodical

Chemical & Engineering News

. ACS journals are among the most cited, most trusted and most read within the scientific literature; however, ACS itself does not conduct chemical research. As a specialist in scientific information solutions (including SciFinder

^®

and STN

^®

), its CAS division powers global research, discovery and innovation. ACS’ main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive news releases from the American Chemical Society, contact

[email protected]

.

Follow us on

Twitter

|

Facebook